44 results
8-K
EX-99.1
ELTX
Elicio Therapeutics Inc.
29 Mar 24
Results of Operations and Financial Condition
8:35am
adaptive immunity required to treat many diseases. In preclinical models, we have observed lymph node-specific engagement driving therapeutic immune … node-specific engagement driving immune responses of increased magnitude, function, and durability. Cautionary Note on Forward-Looking Statements Certain
8-K
EX-99.2
ELTX
Elicio Therapeutics Inc.
9 Jan 24
Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002
8:11am
Early Disease Lymph Node Engagement Exclusively Targeting KRAS Mutations “Off-the-Shelf” Shared KRAS Neoantigen Vaccines Personalized Neoantigen
8-K
EX-99.1
ELTX
Elicio Therapeutics Inc.
9 Nov 23
Results of Operations and Financial Condition
4:41pm
, the AMP platform has demonstrated lymph node- specific engagement driving immune responses of increased magnitude, function, and durability. Society … and persistence of potent adaptive immunity required to treat many diseases. In preclinical models, we have observed lymph node-specific engagement driving
8-K
EX-99.1
ELTX
Elicio Therapeutics Inc.
3 Nov 23
Other Events
5:10pm
many diseases. In preclinical models, we have observed lymph node-specific engagement driving therapeutic immune responses of increased magnitude … on to the protein albumin, found in the bloodstream, as it travels to lymphatic tissue. In preclinical models, we have observed lymph node-specific engagement
8-K
EX-99.2
m7ulsxe
27 Sep 23
Other Events
5:41pm
8-K
EX-99.1
wppj05i jogtw
27 Sep 23
Other Events
5:41pm
8-K
EX-99.1
x7ghfs26qx4mbe2
7 Sep 23
Other Events
8:00am
8-K
EX-99.1
09dtpn3g
11 Aug 23
Elicio Therapeutics Reports Second Quarter 2023 Financial Results and Provides
11:42am
8-K
EX-99.1
4jheb28z0a rx
5 Jun 23
Other Events
8:00am
8-K
EX-10.8
an5u84uyt3u vy
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.5
7tvwafned 92
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.3
l5jdt
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
4ehisvlhpnhrb2n
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.2
m9ja1vedk7g
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.1
3iwghfq3pnp3vd4
1 May 23
Other Events
4:14pm
424B3
w9djg hy1s9
28 Apr 23
Prospectus supplement
4:07pm